pembrolizumab · Medicine question

From what age is pembrolizumab (Keytruda) indicated as monotherapy for unresectable or metastatic melanoma?

Name: From what age is pembrolizumab (Keytruda) indicated as monotherapy for unresectable or metastatic melanoma?
Published: 2026-11-08T14:27:32.877Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Keytruda (pembrolizumab) monotherapy is indicated from 12 years of age for adults and adolescents with advanced (unresectable or metastatic) melanoma.

Sources for this answer

KEYTRUDA 25 mg/mL concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.1 Therapeutic Indications · Version 67Document updated 14 October 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about pembrolizumab